En esta cápsula de ESMO 2025 EXPRESS, el Dr. Sergio Vázquez Estévez, oncólogo médico adscrito al Hospital Universitario Lucus Augusti en Lugo, España, nos habla sobre los principales avances presentados en tumores genitourinarios. El experto comenta lo siguiente: Durante el Congreso Anual de la Sociedad Europea de Oncología Médica 2025, se presentaron resultados que redefinen…
Read MoreDr. Greg Cooper talks with Dr. Jonathan Graff-Redford about key takeaways from the recent Alzheimer’s Association International Conference (AAIC). Disclosures can be found at .
Read MoreCredits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-455 Overview: Microscopic hematuria is common in primary care, but not every patient needs an urgent urology referral. Tune in to learn how to apply the latest evidence-based guidelines to risk-stratify patients and confidently manage workup and follow-up from your clinic, improving…
Read MoreDr. Yaroslau Compta discusses how the view of co-pathologies has changed the view of many disorders, including tauopathies. He dives into the current state of clinical trials for PSP and what those results may mean for the future of biomarkers.
Read MoreRehabilitation for movement disorders, like PD, has become increasingly prevalent for patient care. Prof. Alice Nieuwboer discusses how technology has shaped the field, how neurologists can support patient exercise, and what future updates she looks forward to.
Read MoreThere have been nearly 30 years of disease modifying trials for PD, but little success. Prof. Tanya Simuni breaks down clinical trial design for a heterogenous disease like PD and discusses the future goals and importance of a biological definition.
Read More
